Johnson & Johnson Marketed Rejected Hip Replacements Abroad

Johnson & Johnson continued to market defective metallic hip replacements overseas, even after the Food and Drug Administration (FDA) rejected the product for sale in the United States.

According to The New York Times, in 2009 the FDA did not approve two models of metal hip replacements - including the DePuy’s ASR system - because of a defective design. However, Johnson & Johnson continued to market the joint replacements abroad.

The implants were on the market for a total of eight years and were used in close to 93,000 worldwide DePuy is the orthopedic division of Johnson & Johnson.

If you or a loved one has been harmed a defective metal hip replacement, contact Sokolove Law for a free legal consultation and to learn about your options.

Tags: